Evaluation of serum levels of soluble vascular endothelial (sVE)-Cadherin in early- and late-onset preeclampsia serum sVE-Cadherin levels in preeclampsia

References

• Feletou M. The Endothelium: Part 1: Multiple Functions of the Endothelial Cells-Focus on Endothelium-Derived Vasoactive Mediators. Integrated Systems Physiology: from Molecule to Function to Disease. San Rafael (CA)2011.
   Google Scholar
• Dhananjayan R, Koundinya KS, Malati T, et al. Endothelial Dysfunction in Type 2 Diabetes Mellitus. Indian J Clin Biochem. 2016;31(4):1–7.
   Google Scholar
• Verma S, Anderson TJ. Fundamentals of endothelial function for the clinical cardiologist. Circulation. 2002;105(5):546–9.
   Google Scholar
• Stan RV, Tse D, Deharvengt SJ, et al. The diaphragms of fenestrated endothelia: gatekeepers of vascular permeability and blood composition. Dev Cell. 2012;23(6):1203–18.
   Google Scholar
• Dvorak AM, Feng D. The vesiculo-vacuolar organelle (VVO). A new endothelial cell permeability organelle. J Histochem Cytochem. 2001;49(4):419–32.
   Google Scholar
• Giannotta M, Trani M, Dejana E. VE-cadherin and endothelial adherens junctions: active guardians of vascular integrity. Dev Cell. 2013;26(5):441–54.
   Google Scholar
• Zhang R, Li R, Tang Y. Soluble vascular endothelial cadherin: a promising marker of critical illness? Crit Care. 2019;23(1):57.
   Google Scholar
• Dejana E, Orsenigo F. Endothelial adherens junctions at a glance. J Cell Sci. 2013;126(Pt 12):2545–9.
   Google Scholar
• Dejana E, Orsenigo F, Lampugnani MG. The role of adherens junctions and VE-cadherin in the control of vascular permeability. J Cell Sci. 2008;121(Pt 13):2115–22.
   Google Scholar
• Blaise S, Polena H, Vilgrain I. Soluble vascular endothelial-cadherin and auto-antibodies to human vascular endothelial-cadherin in human diseases: Two new biomarkers of endothelial dysfunction. Vasc Med. 2015;20(6):557–65.
   Google Scholar
• Poon LC, Shennan A, Hyett JA, et al. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention. Int J Gynaecol Obstet. 2019;145 Suppl 1:1–33.
   Google Scholar
• Eaton BM, Leach L, Firth JA. Permeability of the fetal villous microvasculature in the isolated perfused term human placenta. J Physiol. 1993;463(1):141–155. doi:10.1113/jphysiol.1993.sp019588.
   PubMedGoogle Scholar
• Leach L, Clark P, Lampugnani MG, et al. Immunoelectron characterisation of the inter-endothelial junctions of human term placenta. J Cell Sci. 1073;104 (Pt 4):1073–1081. doi:10.1242/jcs.104.4.1073.
   PubMed Web of Science ®Google Scholar
• Gavard J. Endothelial permeability and VE-cadherin: a wacky comradeship. Cell Adh Migr. 2013;7(6):455–461. doi:10.4161/cam.27330.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Damsky CH, Fisher SJ. Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome? J Clin Invest. 1997;99(9):2152–2164. doi:10.1172/JCI119388.
   PubMed Web of Science ®Google Scholar
• Kawashima M, Kitagawa M. An immunohistochemical study of cadherin 5 (VE-cadherin) in vascular endothelial cells in placentas with gestosis. J Obstet Gynaecol Res. 1998;24(6):375–384. doi:10.1111/j.1447-0756.1998.tb00112.x.
   PubMedGoogle Scholar
• Li Y, Zhao YJ, Zou QY, et al. Preeclampsia does not alter vascular growth and expression of CD31 and vascular endothelial cadherin in human placentas. J Histochem Cytochem. 2015;63(1):22–31. doi:10.1369/0022155414558063.
   PubMed Web of Science ®Google Scholar
• Leach L, Gray C, Staton S, et al. Vascular endothelial cadherin and beta-catenin in human fetoplacental vessels of pregnancies complicated by Type 1 diabetes: associations with angiogenesis and perturbed barrier function. Diabetologia. 2004;47(4):695–709. doi:10.1007/s00125-004-1341-7.
   PubMed Web of Science ®Google Scholar
• Brown N, Khan F, Alshaikh B, et al. CD-34(+) and VE-cadherin(+) endothelial progenitor cells in preeclampsia and normotensive pregnancies. Pregnancy Hypertens. 2019;16:42–47. doi:10.1016/j.preghy.2019.02.007.
   PubMed Web of Science ®Google Scholar
• Yoder MC. Human endothelial progenitor cells. Cold Spring Harb Perspect Med. 2012;2(7):a006692–a006692. doi:10.1101/cshperspect.a006692.
   PubMed Web of Science ®Google Scholar
• Soeki T, Tamura Y, Shinohara H, et al. Elevated concentration of soluble vascular endothelial cadherin is ­associated with coronary atherosclerosis. Circ J. 2004;68(1):1–5. doi:10.1253/circj.68.1.
   PubMed Web of Science ®Google Scholar
• Sidibé A, Mannic T, Arboleas M, et al. Soluble VE-cadherin in rheumatoid arthritis patients correlates with disease activity: evidence for tumor necrosis factor alpha-induced VE-cadherin cleavage. Arthritis Rheum. 2012;64(1):77–87. doi:10.1002/art.33336.
   PubMedGoogle Scholar
• Banse C, Polena H, Stidder B, et al. Soluble vascular endothelial (VE) cadherin and autoantibodies to VE-cadherin in rheumatoid arthritis patients treated with etanercept or adalimumab. Joint Bone Spine. 2017;84(6):685–691. doi:10.1016/j.jbspin.2016.10.012.
   PubMed Web of Science ®Google Scholar
• Chen T, Guo ZP, Cao N, et al. Increased serum levels of soluble vascular endothelial-cadherin in patients with systemic vasculitis. Rheumatol Int. 2014;34(8):1139–1143. doi:10.1007/s00296-014-2949-7.
   PubMed Web of Science ®Google Scholar
• Doulgere J, Otto B, Nassour M, et al. Soluble plasma VE-cadherin concentrations are elevated in patients with STEC infection and haemolytic uraemic syndrome: a case-control study. BMJ Open. 2015;5(3):e005659–e005659. doi:10.1136/bmjopen-2014-005659.
   PubMed Web of Science ®Google Scholar
• Chen T, Guo ZP, Wang WJ, et al. Increased serum soluble vascular endothelial cadherin levels in patients with chronic spontaneous urticaria. Ann Allergy Asthma Immunol. 2017;118(6):704–709. doi:10.1016/j.anai.2017.04.013.
   PubMed Web of Science ®Google Scholar
• Budzyń M, Iskra M, Turkiewicz W, et al. Plasma concentration of selected biochemical markers of endothelial dysfunction in women with various severity of chronic venous insufficiency (CVI)-a pilot study. PLoS One. 2018;13(1):e0191902. doi:10.1371/journal.pone.0191902.
   PubMed Web of Science ®Google Scholar
• Alexander JS, Alexander BC, Eppihimer LA, et al. Inflammatory mediators induce sequestration of VE-cadherin in cultured human endothelial cells. Inflammation. 2000;24(2):99–113. doi:10.1023/a:1007025325451.
   PubMed Web of Science ®Google Scholar
• Zhao X, Alexander JS, Zhang S, et al. Redox regulation of endothelial barrier integrity. Am J Physiol Lung Cell Mol Physiol. 2001;281(4):L879–86. doi:10.1152/ajplung.2001.281.4.L879.
   PubMed Web of Science ®Google Scholar
• Guzmán-Guzmán IP, Zaragoza-García O, Vences-Velázquez A[, et al. Circulating levels of MCP-1, VEGF-A, sICAM-1, sVCAM-1, sE-selectin and sVE-cadherin: relationship with components of metabolic syndrome in young population. ]. Med Clin (Barc). 2016;147(10):427–434. doi:10.1016/j.medcli.2016.06.028.
   PubMed Web of Science ®Google Scholar